Duke University joined Vivli as a founding Member organization, expressing their support for Vivli’s mission:
“Duke University School of Medicine is pleased to partner with Vivli to foster the principles of open science and data access from clinical studies,” said Adrian Hernandez, MD, Vice Dean for Clinical Research, Duke University School of Medicine. “At Duke, we are committed to developing research polices, platforms and methods to provide appropriate access to research information, with the ultimate goal of expediting the development of new treatments to improve the health of patients around the world.”
Dr. Frank Rockhold, Professor of Biostatistics and Bioinformatics at Duke Clinical Research Institute, has long supported the mission of Vivli. Dr. Rockhold, pictured below at the Vivli launch event in July, has contributed valuable insights through the development of the Vivli platform.
Professor of Biostatistics and Bioinformatics Dr. Frank Rockhold, DCRI, speaking at the Vivli Platform launch
Duke shared their excitement about joining Vivli with a statement on their website, published to coincide with Vivli’s launch on July 19:
“The Duke University School of Medicine is pleased to announce our partnership with Vivli to foster the principles of open science and data access from clinical studies. This is the culmination of years of cooperative efforts between Vivli and Duke to develop the principles and infrastructure to support this effort. We took our experience from implementing our platforms (SOAR, Get Data at Duke, Duke Data Service) to create an even higher-level mission for the school.”
“At the Duke University School of Medicine, we are committed to developing research polices, platforms and methods to provide…
- Appropriate access to research information, so patient privacy is maintained, with the understanding that the nature of the study and sharing method will necessitate a range of privacy controls
- Proper oversight with minimum barriers to data access, to prevent against misuse of data, while promoting new discovery
- Maintaining utility of data, such that shared data can be used for new analyses
- An expectation that results of analyses from shared data will similarly be shared
- Acknowledgement of the work of original contributors
- We expect to apply these principles to apply to clinical trials sponsored or conducted by Duke and also set an expectation for our research partners. We feel these principles are in complete alignment with those of Vivli.
- We look forward to working with the Vivli leadership and their other Partners on the successful launch of the Vivli Platform. We are confident this effort will facilitate the delivery of clinical trial transparency.”